Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, A. Schneeweiss, Fabio Puglisi, Tamar Peretz‐Yablonski, Mario Campone, Igor Bondarenko, Zbigniew Nowecki, Hassan Errihani, Shani Paluch–Shimon, A. Wardley, Jean-Louis Merot, Peter C. Trask, Yolande Du Toit, Claudia Peña-Murillo, Valentine Revelant, Dirk Klingbiel, T. Bachelot, T. Bachelot, K. Bouzid, Mario Campone, Isabelle Desmoulins, Bruno Coudert, Igor Bondarenko, Zbigniew Nowecki, I. Głogowska, Eva Ciruelos Gil, Hassan Errihani, Florence Dalenc, Francesco Ricci, Véronique Dièras, Bella Kaufman, Shani Paluch–Shimon, A. Wardley, A. Schneeweiss, Ana Filipa Ferreira, Max S. Mano, Haralabos P. Kalofonos, Claudia Andreetta, F. Puglisi, Filippo Montemurro, Sophie Barrett, Q. Zhang, Dimitriοs Mavroudis, Juan Antonio Matus, C. Villarreal Garza, C. Beato, Gustavo Ismael, Xiaoyu Hu, Hamdy Abdel Azeem, Rabab Gaafar, Christophe Perrin, Pierre Kerbrat, Johannes Ettl, Stefan Paepke, Erika Hitre, István Láng, Marc Trudeau, Sunil Verma, H. Li, Oliver Hoffmann, Bahriye Aktas, Anna Cariello, G. Cruciani, A. Tienghi, Carlo Tondini, T. Al-Twegieri, Niklas Loman, Robert Laing, David Miles, Étienne Brain, Peter A. Fasching, Michael P. Lux, Antonio Frassoldati, Zeba Aziz, J. Fernando Salas, Joanna Streb, K. Krzemieniecki, A Wroński, J. García García, Salomón Menjón Beltrán, I. Cicin, Peter Schmid, Chris Gallagher, Nicholas C. Turner, Zhongsheng Tong, Katalin Boér, Balázs Juhász, Zsolt Horváth, Giampaolo Bianchini, Luca Gianni, Giuseppe Curigliano, Alejandro Juárez Ramiro, Sneẑana Šušnjar, Eduarda Matos, Elena Sevillano, L. Garcia Estevez, Erhan Gökmen, Rüçhan Uslu, Hans Wildiers